Thermo Fisher Scientific is acquiring Clario for roughly $8.9 billion, a major move to boost its clinical research services.
Velan Inc. Reports Solid Performance In The Third Quarter Of Fiscal 2026. MONTREAL, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Velan Inc. (TSX: VLN) (“Velan” or the“Company”), a world-leading manufacturer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback